# Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Study · id `cardio:ct-nct03371355` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03371355](<https://clinicaltrials.gov/study/NCT03371355>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03371355

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT03371355. Randomized; triple masking; primary purpose treatment. Start 2017-12-21 (actual); primary completion 2019-11-21 (actual). Results posted on 2021-02-01.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT03371355, source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)
- Started: 2017-12-21 (actual) (ClinicalTrials.gov record NCT03371355, source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)
- Primary completion: 2019-11-21 (actual) (ClinicalTrials.gov record NCT03371355, source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)
- Completion: 2020-02-24 (actual) (ClinicalTrials.gov record NCT03371355, source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)
- Results first posted: 2021-02-01 (ClinicalTrials.gov record NCT03371355, source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT03371355, source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03371355-2021-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
- Condition: NAFLD
- Condition: Diabetes Mellitus, Type 2
- Condition: Hypertriglyceridemia
- Condition: Fatty Liver, Nonalcoholic
- Intervention (Drug): Placebo
- Intervention (Drug): ISIS 703802 40 mg
- Intervention (Drug): ISIS 703802 80 mg
- Intervention (Drug): ISIS 703802 20 mg
- Lead sponsor: Akcea Therapeutics
- Lead sponsor class: INDUSTRY
- Collaborator: Ionis Pharmaceuticals, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Akcea Therapeutics (`cardio:org-akcea-therapeutics`)
- Registry lists this organization as a collaborator: Ionis Pharmaceuticals, Inc. (`cardio:org-ionis-pharmaceuticals-inc`)

## Provenance

Content hash: 121d2504390b2345013fff22b0ba6f4aea6630edeb9821629a7bd0861d7932e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
